Screener
ANI Pharmaceuticals ANIP Increase Decrease Accrued Government Rebates
Increase Decrease Accrued Government Rebates at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept anip:IncreaseDecreaseAccruedGovernmentRebates.
The source filing: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026. Open the filing →
- Filed
- May 8, 2026, 6:58 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001023024-26-000050
FAQ
- What is ANI Pharmaceuticals's increase decrease accrued government rebates?
- ANI Pharmaceuticals (ANIP) reported increase decrease accrued government rebates of -$4.74M in Q1 2026.
- How has ANI Pharmaceuticals's increase decrease accrued government rebates changed year-over-year?
- ANI Pharmaceuticals's increase decrease accrued government rebates decreased by 220.5% year-over-year, from $3.93M to -$4.74M.
- What is the long-term trend for ANI Pharmaceuticals's increase decrease accrued government rebates?
- Over 2 years (2021 to 2025), ANI Pharmaceuticals's increase decrease accrued government rebates has grown at a 181.8% compound annual growth rate (CAGR), from -$3.08M to $24.44M.
- What does increase decrease accrued government rebates mean?
- Increase Decrease Accrued Government Rebates as reported by ANI Pharmaceuticals, Inc..
Ask your AI about ANI Pharmaceuticals's increase decrease accrued government rebates.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude